About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Phase IV-Cervical Dystonia-INTEREST IN CD2

NCT01753349·113 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Ipsen

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Subject for whom there is an intention to treat with BoNT-A.
BoNT treatment naïve or previously treated with BoNT.
If previously treated with BoNT, at least a 12-week interval between the last injection (BoNT-A or BoNT-B) and inclusion.
Subject able to comply with the protocol.
Provision of written informed consent prior to collect the data.

You may not be if

Contraindications to any BoNT-A preparations.
The subject has already been included in the study.

The record

StatusCompleted

PhaseNo phase

Taking part1,050

StartedDec 2012

UpdatedNov 5, 2020

Conditions

Cervical Dystonia

Where113

Parkinson's and Movement Disorders Center of Maryland
Elkridge, Maryland, United States
Tufts Medical Center, Inc
Boston, Massachusetts, United States
The Parkinson's and Movement Disorders Center
Southfield, Michigan, United States

Clareo Health | Phase IV-Cervical Dystonia-INTEREST IN CD2